Among breast cancer subtypes, the highest frequency of fusion genes was observed in the hormone receptor-negative (HR‒)/human epidermal growth factor receptor 2-positive (HER2+) subtype (Fig. 1f). This evidence concerns the gene ERBB2 and breast carcinoma.